Studies related to Attention and L-Carnitine

Acetyl-L-carnitine Reduces Depression And Improves Quality Of Life In Patients With Minimal Hepatic Encephalopathy

Effect Decrease
Values Trail-making A. Mean and SD. Placebo: before 39.6 ± 5.6, after 38 ± 5.4. Carnitine: before 42.8 ± 5.5, after 36 ± 3.8 Trail-making B. Placebo: before 63.5 ± 5.7, after 59.4 ± 5.5. Carnitine: before 57.8 ± 7, after 46.2 ± 6.5
Trial Design Double blind
Trial Length n/a
Number of Subjects 67
Sex n/a
Notes for this study:
Acetyl-L-Carnitine at 4g a day (2g, twice a day) was associated with decreased depression and improved quality of life as a result of hepatic encepalopathy.

Full details on all 5 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.